相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。One-Step Analysis of DNA/Chitosan Complexes by Field-Flow Fractionation Reveals Particle Size and Free Chitosan Content
Pei Lian Ma et al.
BIOMACROMOLECULES (2010)
Enhanced Gene Delivery Mediated by Low Molecular Weight Chitosan/DNA Complexes: Effect of pH and Serum
Surendra Nimesh et al.
MOLECULAR BIOTECHNOLOGY (2010)
Intracellular Trafficking and Decondensation Kinetics of Chitosan-pDNA Polyplexes
Marc Thibault et al.
MOLECULAR THERAPY (2010)
New Insights into Chitosan-DNA Interactions Using Isothermal Titration Microcalorimetry
Pei Lian Ma et al.
BIOMACROMOLECULES (2009)
Degradation of Chitosans with Chitinase G from Streptomyces coelicolor A3(2): Production of Chito-oligosaccharides and Insight into Subsite Specificities
Ellinor B. Heggset et al.
BIOMACROMOLECULES (2009)
Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies
M. Jean et al.
GENE THERAPY (2009)
被撤回的出版物: Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons (Retracted article. See vol. 31, pg. 8698, 2011)
Xiaosong Ma et al.
JOURNAL OF NEUROSCIENCE (2007)
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis
Young-Sun Lee et al.
DIABETES (2007)
Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1
Meng-Ju Liu et al.
MOLECULAR THERAPY (2007)
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
G. B. Parsons et al.
GENE THERAPY (2007)
High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation
Marc Lavertu et al.
BIOMATERIALS (2006)
Gastrointestinal hormones regulating appetite
Owais Chaudhri et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
GA Herman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
B Ahrén et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cationic polymers that enhance the performance of HbsA9 DNA in vivo
GW Bos et al.
VACCINE (2004)
The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo
M Miller et al.
VACCINE (2004)
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
PL Brubaker et al.
ENDOCRINOLOGY (2004)
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
N Vrang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Mitochondrial dysfunction in the elderly: Possible role in insulin resistance
KF Petersen et al.
SCIENCE (2003)
Development and characterization of a glucagon-like peptide 1-albumin conjugate -: The ability to activate the glucagon-like peptide 1 receptor in vivo
JG Kim et al.
DIABETES (2003)
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice
B Rolin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
The role of pancreatic duodenum homeobox protein-1 in the development of diabetes mellitus
JF Habener
DRUG NEWS & PERSPECTIVES (2002)
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Q Wang et al.
DIABETOLOGIA (2002)
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
HX Hui et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
MA Nauck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats
S Hoshi et al.
LABORATORY INVESTIGATION (2002)
Diabetes mellitus and genetically programmed defects in β-cell function
GI Bell et al.
NATURE (2001)
Local high-capacity adenovirus-mediated mCTLA4lg and mCD40lg expression prolongs recombinant gene expression in skeletal muscle
ZL Jiang et al.
MOLECULAR THERAPY (2001)
Liposome-mediated high-efficiency transfection of human endothelial cells
S Kaiser et al.
JOURNAL OF VASCULAR RESEARCH (2001)
A mucosal vaccine against diphtheria:: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
EA McNeela et al.
VACCINE (2000)
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
M Dupuis et al.
JOURNAL OF IMMUNOLOGY (2000)
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
DA Stoffers et al.
DIABETES (2000)
分享论文
